Herman Kalman Gold

Herman Kalman Gold's AcademicInfluence.com Rankings

Herman Kalman Gold

Philosophy

#8487

World Rank

#11877

Historical Rank

Logic

#5516

World Rank

#6921

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Herman Kalman Gold's Degrees

Doctorate Medicine University of California, San Francisco
PhD Biomedical Sciences University of California, San Francisco

Why Is Herman Kalman Gold Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Herman Kalman Gold's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. (2006) (2777)
Intraplaque hemorrhage and progression of coronary atheroma. (2003) (1405)
Atherosclerotic Plaque Progression and Vulnerability to Rupture: Angiogenesis as a Source of Intraplaque Hemorrhage (2005) (1310)
Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization (2007) (1286)
Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing (2007) (902)
Endothelial cell recovery between comparator polymer-based drug-eluting stents. (2008) (653)
The thin-cap fibroatheroma: a type of vulnerable plaque: The major precursor lesion to acute coronary syndromes (2001) (646)
Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction Patients: An Autopsy Study (2008) (592)
Differential Response of Delayed Healing and Persistent Inflammation at Sites of Overlapping Sirolimus- or Paclitaxel-Eluting Stents (2005) (577)
Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation. (1988) (437)
Pathologic assessment of the vulnerable human coronary plaque (2004) (422)
Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. (1996) (400)
Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial. (1984) (389)
Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis. (1989) (368)
Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. (1998) (368)
Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. (2005) (362)
Comparison Between the Effects of Nitroprusside and Nitroglycerin on Ischemic Injury during Acute Myocardial Infarction (1976) (358)
Unstable angina pectoris: National cooperative study group to compare surgical and medical therapy: II. In-Hospital experience and initial follow-up results in patients with one, two and three vessel disease (1978) (328)
Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. (1986) (324)
Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3,697 patients. (1983) (309)
Ventricular Septal Rupture: A Review of Clinical and Physiologic Features and an Analysis of Survival (1981) (266)
Targeting of Apoptotic Macrophages and Experimental Atheroma With Radiolabeled Annexin V: A Technique With Potential for Noninvasive Imaging of Vulnerable Plaque (2003) (262)
Right ventricular infarction. Clinical diagnosis and differentiation from cardiac tamponade and pericardial constriction. (1974) (258)
Use of Sublingual Nitroglycerin in Congestive Failure following Acute Myocardial Infarction (1972) (256)
Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs. (1988) (239)
Surgery for Post‐Myocardial Infarct Ventricular Septal Defect (1977) (226)
Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition. (1990) (210)
Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. (1996) (210)
Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody. (1986) (203)
Real-Time Catheter Molecular Sensing of Inflammation in Proteolytically Active Atherosclerosis (2008) (192)
Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris. (1990) (191)
Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris. (1993) (187)
Propranolol-induced reduction of signs of ischemic injury during acute myocardial infarction. (1976) (186)
Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. (2002) (171)
Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial. (1994) (168)
Monoclonal antibody to cardiac myosin: imaging of experimental myocardial infarction. (1984) (167)
Comprehensive assessment of myocardial perfusion defects, regional wall motion, and left ventricular function by using 64-section multidetector CT. (2008) (166)
Monoclonal Antibodies to Platelet Glycoprotein IIb/IIIa as Antithrombotic Agents a (1991) (165)
Reperfused myocardial infarction: contrast-enhanced 64-Section CT in comparison to MR imaging. (2008) (161)
Acute myocardial infarct imaging with indium-111-labeled monoclonal antimyosin Fab. (1987) (161)
Coronary thrombolysis with recombinant human tissue-type plasminogen activator. (1984) (158)
Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators. Observations in animals and humans. (1997) (158)
Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. (1984) (156)
Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. (2003) (153)
Indium 111-monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis. (1987) (150)
Intracoronary thrombolysis in syndromes of unstable ischemia: angiographic and clinical results. (1982) (145)
A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris. (1987) (142)
Percutaneous transvenous cellular cardiomyoplasty (2002) (140)
Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparation. (1990) (138)
Intraaortic Balloon Pumping for Ventricular Septal Defect or Mitral Regurgitation Complicating Acute Myocardial Infarction (1973) (137)
Unstable angina pectoris: National Cooperative Study Group to Compare Surgical and Medical Therapy. (1976) (132)
Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial. (1984) (129)
Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization (2007) (129)
Lysis of plasminogen activator-resistant platelet-rich coronary artery thrombus with combined bolus injection of recombinant tissue-type plasminogen activator and antiplatelet GPIIb/IIIa antibody. (1990) (126)
Intra‐aortic Balloon Pump Assist for Cardiogenic Shock After Cardiopulmonary Bypass (1973) (125)
Atrial fibrillation in patients with idiopathic hypertrophic subaortic stenosis (1970) (120)
A dilemma for the 1990s. Choosing appropriate experimental animal model for the prevention of restenosis. (1992) (118)
Prevention of coronary artery reocclusion and reduction in late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction. A randomized study of maintenance infusion of recombinant human tissue-type plasminogen activator. (1988) (116)
Diagnosis of acute myocardial infarction by detection of circulating cardiac myosin light chains. (1984) (114)
Improved Results of Surgical Management of Postinfarction Ventricular Septal Rupture (1982) (109)
Differentiation of recent and chronic myocardial infarction by cardiac computed tomography. (2006) (108)
Correlation between template bleeding times and spontaneous bleeding during treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator. (1989) (107)
Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (Fab) imaging. (1987) (106)
Comparative properties of two clinical preparations of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction. (1987) (106)
Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. (2005) (99)
Detection of coronary artery reperfusion with creatine kinase-MB determinations during thrombolytic therapy: correlation with acute angiography. (1988) (99)
Kistrin, a Polypeptide Platelet GPIIb/IIIa Receptor Antagonist, Enhances and Sustains Coronary Arterial Thrombolysis With Recombinant Tissue‐Type Plasminogen Activator in a Canine Preparation (1991) (97)
Cardiopulmonary Bypass Induces Release of Soluble CD40 Ligand (2002) (96)
Unstable angina pectoris: national cooperative study group to compare medical and surgical therapy. I. Report of protocol and patient population. (1976) (95)
Myocardial damage delineated by indium-111 antimyosin Fab and technetium-99m pyrophosphate. (1987) (91)
Intraaortic Balloon Pumping for Control of Recurrent Myocardial Ischemia (1973) (91)
Early Intraaortic Balloon Pumping for Anterior Myocardial Infarction Without Shock (1978) (91)
Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS Study. (1986) (91)
Coronary reocclusion after selective administration of streptokinase. (1983) (91)
Site-Specific Targeting of Nanoparticle Prednisolone Reduces In-Stent Restenosis in a Rabbit Model of Established Atheroma (2008) (88)
In vivo thrombin inhibition enhances and sustains arterial recanalization with recombinant tissue-type plasminogen activator. (1990) (85)
Comparative Thrombolytic Properties of Tissue-Type Plasminogen Activator and of a Plasminogen Activator Inhibitor-1 -Resistant Glycosylation Variant, in a Combined Arterial and Venous Thrombosis Model in the Dog (1994) (84)
The relationship of myocardial infarct size and prognosis. (1976) (83)
Surgical management of ventricular septal defects and mitral regurgitation complicating acute myocardial infarction. (1973) (83)
Pioglitazone Inhibits In-Stent Restenosis in Atherosclerotic Rabbits by Targeting Transforming Growth Factor-&bgr; and MCP-1 (2007) (78)
Dose-dependent thrombolysis, pharmacokinetics and hemostatic effects of recombinant human tissue-type plasminogen activator for coronary thrombosis. (1986) (77)
Combined intracoronary streptokinase infusion and coronary angioplasty during acute myocardial infarction. (1984) (76)
Continuous monitoring of left ventricular function by an ambulatory radionuclide detector in patients with coronary artery disease. (1988) (75)
Inhaled nitric oxide increases coronary artery patency after thrombolysis. (1996) (75)
Technetium-99m labeling of antibodies to cardiac myosin Fab and to human fibrinogen. (1982) (74)
Efficient repopulation of denuded rabbit arteries with autologous genetically modified endothelial cells. (1994) (73)
Early Imaging of Experimental Myocardial Infarction by Intracoronary Administration of 1311-Labelled Anticardiac Myosin (Fab')2 Fragments (1978) (68)
Coronary stent assessability by 64 slice multi‐detector computed tomography (2007) (66)
Directional coronary atherectomy for the treatment of Palmaz-Schatz in-stent restenosis. (1998) (66)
The Role of Angiography in Cardiogenic Shock (1973) (64)
Animal models for arterial thrombolysis and prevention of reocclusion. Erythrocyte-rich versus platelet-rich thrombus. (1991) (61)
Safe Early Revascularization for Continuing Ischemia After Acute Myocardial Infarction (1979) (59)
Antithrombotic effect of a monoclonal antibody against tissue factor in a rabbit model of platelet-mediated arterial thrombosis. (1992) (59)
Effect of alterations in the thyroid state on the intrinsic contractile properties of isolated rat skeletal muscle. (1970) (55)
A Novel Rat Model of Carotid Artery Stenting for the Understanding of Restenosis in Metabolic Diseases (2002) (54)
Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents. (2008) (54)
Effects of experimental heart failure on the capacity of glucagon to augment myocardial contractility and activate adenyl cyclase. (1970) (54)
Unstable angina pectoris: national cooperative study group to compare surgical and medical therapy. III. Results in patients with S-T segment elevation during pain. (1980) (54)
Survival Following Mitral Valve Replacement for Mitral Regurgitation due to Coronary Artery Disease (1979) (53)
A canine model of coronary artery thrombosis with superimposed high grade stenosis for the investigation of rethrombosis after thrombolysis. (1989) (53)
Drug-eluting stents for diabetes mellitus: a rush to judgment? (2005) (51)
Surgical Intervention for the Complications of Acute Myocardial Ischemia (1973) (50)
A chimeric murine/human antibody Fab fragment directed against the platelet GPIIb/IIIa receptor enhances and sustains arterial thrombolysis with recombinant tissue-type plasminogen activator in baboons. (1993) (49)
Detection of Serum Cardiac Myosin Light Chains in Acute Experimental Myocardial Infarction: Radioimmunoassay of Cardiac Myosin Light Chains (1978) (48)
Serial evaluation of right ventricular dysfunction associated with acute inferior myocardial infarction. (1990) (45)
Quantitation of acute myocardial infarct size by nuclear magnetic resonance imaging. (1990) (43)
Refractory angina pectoris: follow-up after intraaortic balloon pumping and surgery. (1976) (42)
A simplified method to predict occurrence of complete heart block during acute myocardial infarction (1986) (40)
Control of Postinfarction Ventricular Irritability with the Intraaortic Balloon Pump (1980) (39)
Anterior ST segment depression in acute inferior myocardial infarction as a marker of greater inferior, apical, and posterolateral damage. (1986) (39)
Role of right ventricular infarction in cardiogenic shock associated with inferior myocardial infarction. (1979) (38)
Conjunctive antithrombotic and thrombolytic therapy for coronary-artery occlusion. (1990) (38)
Management of Acute Myocardial Ischemia with Intraaortic Balloon Pumping and Coronary Bypass Surgery (1978) (36)
Differentiation of regional perfusion and fatty acid uptake in zones of myocardial injury (1991) (33)
Hemodynamic Evaluation of Glucagon in Symptomatic Heart Disease (1971) (32)
Unstable angina pectoris: National Cooperative Study Group to Compare Medical and Surgical Therapy. IV. Results in patients with left descending coronary artery disease. (1981) (32)
Comparison of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty as initial treatment strategies. (1989) (30)
Transient thrombotic state after abrupt discontinuation of heparin in percutaneous coronary angioplasty. (1996) (30)
Bleeding time prolongation and bleeding during infusion of recombinant tissue-type plasminogen activator in dogs: potentiation by aspirin and reversal with aprotinin. (1991) (30)
Synergistic Antithrombotic Properties of G4120, a RGD-Containing Synthetic Peptide, and Argatroban, a Synthetic Thrombin Inhibitor, in a Hamster Femoral Vein Platelet-Rich Thrombosis Model (1992) (29)
Differential Healing After Sirolimus, Paclitaxel, and Bare Metal Stent Placement in Combination With Peroxisome Proliferator-Activator Receptor &ggr; Agonists: Requirement for mTOR/Akt2 in PPAR&ggr; Activation (2009) (28)
Utility of cardiovascular magnetic resonance to predict left ventricular recovery after primary percutaneous coronary intervention for patients presenting with acute ST-segment elevation myocardial infarction. (2007) (27)
Intraaortic balloon pumping and emergency coronary arterial revascularization for acute myocardial infarction with impending extension. (1973) (27)
Prospective study of medical and urgent surgical therapy in randomizable patients with unstable angina pectoris: results of in-hospital and chronic mortality and morbidity. (1981) (26)
Relation of segmental wall motion to global left ventricular function in acute myocardial infarction. (1983) (26)
Percutaneous wire-guided balloon pumping. (1982) (25)
Synergistic combinations of recombinant human tissue-type plasminogen activator and human single-chain urokinase-type plasminogen activator. Effect on thrombolysis and reocclusion in a canine coronary artery thrombosis model with high-grade stenosis. (1989) (24)
Effects of psychopharmacologic agents on myocardial contractility. (1970) (24)
Intravenous and endobronchial administration of G4120, a cyclic Arg-Gly-Asp-containing platelet GPIIb/IIIa receptor-blocking pentapeptide, enhances and sustains coronary arterial thrombolysis with rt-PA in a canine preparation. (1993) (23)
Prevention of reperfusion dysrhythmias by selective coronary alpha adrenergic blockade (1982) (22)
Electrically induced ventricular arrhythmias in acute myocardial infarction treated with thrombolytic agents. (1988) (22)
Left Ventricular Function During Intra-aortic Balloon Pumping Assessed by Multigated Cardiac Blood Pool Imaging (1978) (22)
Towards better thrombolytic therapy. (1991) (22)
Enzymatic estimation of myocardial infarct size when early creatine kinase values are not available. (1983) (22)
New developments in thrombolytic therapy. (1989) (21)
G4120, an Arg-Gly-Asp Containing Pentapeptide, Enhances Arterial Eversion Graft Recanalization with Recombinant Tissue-Type Plasminogen Activator in Dogs (1992) (21)
Left ventricular functional recovery with percutaneous, transvascular direct myocardial delivery of bone marrow-derived cells. (2005) (21)
Effect of hyaluronidase on mortality and morbidity in patients with early peaking of plasma creatine kinase MB and non-transmural ischaemia. Multicentre investigation for the limitation of infarct size (MILIS). (1988) (21)
Cessation of platelet-mediated cyclic canine coronary occlusion after thrombolysis by combining nitric oxide inhalation with phosphodiesterase-5 inhibition. (2001) (21)
Regional streptokinase in myocardial infarction. (1981) (19)
Abstract of papers to be Presented at the 29th Annual Scientific Session of the American College of Cardiology Houston, Texas, March 9 to 13, 1980Coronary obstruction in anterior myocardial infarction: Thrombus or spasm? (1980) (19)
Contribution of platelets and the vessel wall to the antithrombotic effects of a single bolus injection of Fab fragments of the antiplatelet GPIIb/IIIa antibody 7E3 in a canine arterial eversion graft preparation. (1994) (19)
Comparison between the effects of nitroglycerin and nitroprusside on ischemic injury during acute myocardial infarction (1976) (19)
Spontaneous changes in regional wall motion abnormalities in acute myocardial infarction. (1986) (19)
Laboratory monitoring of hemostasis during thrombolytic therapy with recombinant human tissue-type plasminogen activator. (1988) (19)
New developments in thrombolytic therapy. (1990) (18)
Effect of immediate angioplasty on coronary patency following infarct therapy with streptokinase (1982) (18)
Intraplaque hemorrhage and progression of coronary atheroma (2004) (18)
Patterns of haemodynamic alteration during left ventricular ischaemia in man. Relation to angiographic extent of coronary artery disease. (1979) (16)
Usefulness of intravenous propranolol in predicting left anterior descending blood flow during anterior myocardial infarction. (1984) (16)
Reversal of ouabain and acetyl strophanthidin effects in normal and failing cardiac muscle by specific antibody. (1974) (16)
Temporal relation between left ventricular dysfunction and chest pain in coronary artery disease during activities of daily living. (1990) (15)
Absence of Potentiation with Murine Antiplatelet GPIIb/IIIa Antibody of Thrombolysis with Recombinant Tissue-Type Plasminogen Activator (rt-PA) in a Canine Venous Thrombosis Model (1989) (14)
Time course of the effects of a single bolus injection of F(ab')2 fragments of the antiplatelet GPIIb/IIIa antibody 7E3 on arterial eversion graft occlusion, platelet aggregation, and bleeding time in dogs. (1994) (14)
Effects of G4120, a Arg-Gly-Asp containing synthetic platelet glycoprotein IIB/IIIA receptor antagonist, on arterial and venous thrombolysis with recombinant tissue-type plasminogen activator in dogs (1993) (13)
Intracoronary streptokinase in evolving infarction. (1981) (13)
New developments in thrombolytic therapy. (1990) (13)
Effects of G4120, a Arg-Gly-Asp containing synthetic platelet glycoprotein IIB/IIIA receptor antagonist, on arterial and venous thrombolysis with recombinant tissue-type plasminogen activator in dogs (1993) (13)
Effects of G4120, a Arg-Gly-Asp containing synthetic platelet glycoprotein IIB/IIIA receptor antagonist, on arterial and venous thrombolysis with recombinant tissue-type plasminogen activator in dogs (1993) (13)
Alteration of the Left Ventricular Pressure-Volume Relationship in Man and its Effect on the Mitral Echocardiographic Early Diastolic Closure Slope (1977) (12)
Intra-Aortic Balloon Pump Assistance and Early Surgery in Cardiogenic Shock1 (1975) (11)
Wedge pressure monitoring in myocardial infarction. (1971) (11)
Persistent inhibition of arterial thrombosis by a 1‐hour intravenous infusion of argatroban, a selective thrombin inhibitor (1992) (11)
Coronary thrombolysis, conjunctive heparin infusion, and the effect on systemic thrombin activity. (1992) (11)
Thrombolytic therapy for unstable angina pectoris: rationale and results. (1987) (11)
Serial evaluation of right ventricular function after right ventricular infarction (1981) (10)
Predictive factors for in-stent late loss and coronary lesion progression in patients with type 2 diabetes mellitus randomized to rosiglitazone or placebo. (2009) (10)
Coronary artery lesions associated with unstable angina (1975) (9)
Aortocoronary bypass grafting in patients without left main stenosis. Relation of risk factors to early and late survival. (1981) (8)
Abstract of papers to be presented at the twenty-fifth annual scientific session of the American College of Cardiology New Orleans, Louisiana February 23–26, 1976Identifying features of survivors from cardiogenic shock treated with intraaortic balloon pumping☆ (1976) (8)
Influence of pericardiectomy on cat right ventricular function after pulmonary arterial constriction. (1973) (7)
Counterpulsation with an intraaortic balloon: present-day use in the patient with left ventricular ischemia. (1976) (7)
Hemodynamic Evaluation of Rate Augmentation Produced by Atrial Pacing and Isoproterenol in the Early Postoperative Phase of Cardiac Valve Surgery (1971) (6)
Comparison of painful and painless left ventricular dysfunction recorded during ambulatory ventricular function monitoring in angina pectoris secondary to coronary artery disease. (1992) (6)
Coronary angiography during acute myocardial infarction: a search for spasm. (1982) (6)
Effect of Ridogrel, a Combined Thromboxane A2 Synthase Inhibitor/ Prostaglandin Endoperoxide Receptor Antagonist, on the Lysis of Platelet- rich Coronary Arterial Thrombi with Recombinant Tissue-type Plasminogen Activator in a Canine Model (1992) (6)
Surgical Intervention for Preinfarction Angina1 (1975) (6)
A Novel Pharmacodynamic Perfusion Chamber Assay Reveals Superior and Unique Antithrombotic Activities of a Direct-Acting P2Y12 Antagonist, PRT128, Relative to Clopidogrel. (2006) (6)
Right ventricular infarction: Clinical features, emphasizing its resemblance to cardiac tamponade (1978) (5)
Accelerated thrombin generation during anticoagulation in patients with unstable angina pectoris. (1994) (5)
Reduction of in-stent restenosis in porcine coronary arteries after local delivery of adenovirus encoding NOS3 (1999) (5)
Pathology and Pathophysiology of Coronary Atherosclerotic Plaques (2019) (5)
Predictors of Coronary Reflow With Intravenous Chimeric 7E3 Antibody in Acute Myocardial Infarction (1998) (4)
Abstract 2036: In Vivo Imaging of Protease Activity in Atherosclerosis Using A Near-Infrared Fluorescence Intravascular Catheter (2006) (4)
Comparison of image characteristics of In-111-antimyosin and Tc-99m antimyosin in patients with acute myocardial infarction (1985) (4)
Short-term intravenous eptifibatide infusion combined with reduced dose recombinant tissue plasminogen activator inhibits platelet recruitment at sites of coronary artery injury. (2004) (4)
Abstract 2221: Lack of Neointimal Growth is a Predictor of Late Stent Thrombosis (2006) (4)
Reduction of infarct size with thrombolytic agents. (1983) (4)
Correlations of regional wall motion and myocardial perfusion in patients with and without anterior precordial ST segment depression during acute inferior myocardial infarction (1987) (3)
A monoclonal antibody against tissue factor prevents platelet-rich arterial thrombosis in the rabbit (1990) (3)
Use of intracoronary streptokinase in acute myocardial infarction. (1982) (3)
Myocardial effects of angiographic dye (1969) (3)
In Vivo Intravascular Imaging with OCT: Comparison with Ultrasound (2000) (3)
Incidence, severity and clinical course of right ventricular involvement after acute inferior myocardial infarction; assessment by sequential 99Tcm-pyrophosphate scan and gated blood pool scan. (1986) (3)
Recombinant Hirudin for Unstable Angina Pectoris (2005) (3)
Intra-aortic balloon assist for cardiogenic shock and ischemic states at Massachusetts General Hospital. (1976) (2)
Coronary atherosclerosis: morphology and characteristics to identify by evolving imaging technology : Use of imaging techniques to detect atherosclerosis and other forms of vascular injury (1992) (2)
Acute myocardial infarction and thrombolytic therapy. (1990) (2)
Digoxin therapy and mortality following confirmed or suspected myocardial infarction: Experience in the MILIS study (1986) (2)
Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. (1992) (2)
Identification of myocardial ischemia in areas of normal perfusion by rest-dual isotope SPECT with F18 deoxyglucose and Tc99m sestamibi in patients with unstable angina (1999) (2)
Infarct size after reperfusion by simultaneous intracoronary In-111-monoclonal antimyosin and Tc-99mPyrophosphate: Comparison by gamma scintigraphy (1984) (2)
/sup 99m/Tc labeling of antibodies to cardiac myosin Fab and to human fibrinogen (1982) (2)
One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent in patients with diabetes mellitus. (2004) (2)
Editorial: Regional Streptokinase in Myocardial Infarction (1981) (1)
High-risk subgroup of inferior myocardial infarction: importance of anterior wall motion and right ventricular function. (1986) (1)
4 Interaction of recombinant tissue-type plasminogen activator (rt-PA) and murine anti-platelet GPIIb/IIIa monoclonal antibody in a canine femoral vein thrombosis model (1988) (1)
REPRODUCIBILITY OF DYSRHYTHMIA FINDINGS BY A CENTRALIZED LABORATORY WITHIN A MAJOR MULTICENTER TRIAL. (1983) (1)
Intra-aortic ballon counterpulsation: current applications. (1975) (1)
Functional recovery of impaired left ventricular function following revascularization: predictive value of dual energy single photon emission computed tomography with fluorine-18-deoxyglucose and Technetium-99m-sestamibi (1998) (1)
Intraaortic Balloon Pumping for Ventricular Septal Defect (2005) (1)
Comparative efficacy of intravenous eptifibatide, a potent and reversible platelet GP IIb/IIIa receptor antagonist, versus recombinant tissue plasminogen activator for coronary thrombolysis in a canine model (1998) (1)
Total erythrocyte membrane cholesterol: a marker of plaque instability? (2007) (1)
Platelets are not degranulated by a nonionic dimeric contrast agent during diagnostic coronary angiography and coronary interventions (1996) (1)
Inflammation and coronary artery disease (2003) (1)
Pathological Anatomy of Restenosis (2007) (1)
A Possible Explanation for Resistance (2005) (1)
Adjuvant agents to enhance and sustain reperfusion with t-PA : studies in experimental dog models (1991) (1)
Adenoviral Mediated NOS3 Gene Transfer in Porcine Coronary Arteries Reduces In Stent Restenosis (1999) (1)
Persistence of arterial eversion graft patency up to 24 hours following a one hour infusion of argatroban: A selective thrombin inhibitor (1991) (1)
The NHLBI Planning Process: A Streamlined Approach (2005) (0)
Abrogation of apoptosis in atherosclerotic plaques: Feasibility of noninvasive detection by radionuclide imaging with Annexin-V (2003) (0)
Erythrocyte-Rich Versus Platelet-Rich Thrombus (2005) (0)
Basic studies on thrombosis and fibrinolysis (1992) (0)
Coronary artery passivation: a mechanism for the prevention of recurrent ischemia after thrombolysis (2002) (0)
Infarct size imaging by Tc-99m labelled antimyosin antibody: A powerful acute myocardial infarction prognostic tool (1985) (0)
The Relationship Between Coronary Angiographic Patterns and the Effects of Infarct Limiting Interventions (1982) (0)
EARLY ANGIOGRAPHY DURING INFARCTION: A SEARCH FOR SPASM (2009) (0)
Abstract 4921: Differential Healing in Paclitaxel and Sirolimus-Eluting Stents in Combination with Oral PPAR Gamma Agents: The Role of Drug Interaction in Delayed Healing (2008) (0)
Intraaortic balloon pumping: current status and clinical experience. (1973) (0)
Thrombolysis in acute myocardial infarction. (1988) (0)
Injection of bone marrow-derived cells into a porcine myocardial infarction model guided by integration of electroanatomical mapping and magnetic reasonance imaging (2005) (0)
Surgical intervention for preinfarction angina. (1975) (0)
Correlation of regional wall motion after acute myocardial infarction with coronary arteriographic findings (1985) (0)
Is early loss of minimal luminal diameter after successful PTCA prevented by c7E3 IIb/IIIa antiplatelet antibody? (1998) (0)
Arteries With Autologous Genetically Modified Endothelial Cells (2005) (0)
-P100- DETECTION OF RESIDUAL CORONARY THROMBI AFTER REPERFUSION OF EXPERIMENTAL CORONARY THROMBUS USING IN-111 LABELED MONOCLONAL ANTIFIBRIN ANTIBODY : RI : FREE COMMUNICATIONS(I) : PROCEEDINGS OF THE 51th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY (1987) (0)
Reduction of in-stent restenosis by adenoviral-mediated NOS3 gene transfer in porcine coronary arteries (1998) (0)
Abstract 3054: Comparison of Overlapping Non-Polymer versus Polymer-Based DES: Finding a Better Balance Between Neointimal Suppression and Arterial Healing (2006) (0)
Assessment of area involved in patients with acute coronary syndrome by F-18 FDG and Tc-99m-sest amibi dual isotope SPECT (1997) (0)
768-2 Non-culprit Lesions in Acute Myocardial Infarction: Implications for Multiple Plaque Rupture in Acute Coronary Syndromes (1995) (0)
Atherosclerosis / Coronary Heart Disease Short-term Cholesterol Lowering Decreases Size and Severity of Perfusion Abnormalities by Positron Emission Tomography After Dipyridamole in Patients With Coronary Artery Disease : A Potential Noninvasive Marker of Healing Coronary Endothelium (2005) (0)
Clinical Trial Prevention of Coronary Artery Reocclusion and Reduction in Late Coronary Artery Stenosis After Thrombolytic Therapy in Patients With Acute Myocardial Infarction A Randomized Study of Maintenance Infusion of Recombinant Human Tissue-Type Plasminogen Activator (2005) (0)
A Multicenter, Randomized Angiographic Trial (2005) (0)
Coronary Obstruction and Residual Ventricular Function Time from AMI to Collateral to Other Last Time from Coronary Left Anterior Left Anterior Coronary Peak Ejection Anterolateral AMI to Left Patient Age Angiogram Descending Obstruction Descending Disease CPK Fraction Wall Motion Ventriculogram (2005) (0)
The Medical Treatment of Carotid Artery Disease (2008) (0)
INTRACORONARY STREPTOKINASE INFUSION DURING ACUTE MYOCARDIAL INFARCTION (2009) (0)
An Interventionalist's Perspective (2007) (0)
Reocclusion and Reduction in Late Coronary Artery Stenosis After Thrombolytic Therapy (2005) (0)
Coronary angiography: evaluation of atherosclerotic plaques and vascular injury. (1992) (0)
Abstract 1675: Effect of Rosiglitazone versus Placebo on Rapid Angiographic Progression of Non-Culprit Coronary Lesions in Patients with Type 2 DM (2007) (0)
Alternatives to drug eluting stents: safety and efficacy of systemic delivery of antiproliferative therapy to reduce in-stent neointimal hyperplasia (2005) (0)
Contribution of contractile state of the non-infarcted area to global ventricular performance after acute myocardial infarction: assessment by quantitative radionuclide angiography. (1986) (0)
Abstract 1669: Effects of Tumor Necrosis Factor Receptors on Inflammation-Mediated Arterial Remodeling (2006) (0)
Effects of disruption of genes encoding the plasminogen/plasmin system on vascular neointimal formation in mice (1997) (0)
Evolutionary changes in left and right ventricular function in acute myocardial infarction (1987) (0)
Transforming Growth Factor-Pioglitazone Inhibits In-Stent Restenosis in Atherosclerotic Rabbits by Targeting (2006) (0)
Effect of acute coronary angio plasty on re perfusion success rate with intra coronary thrombolysis in acute myo cardial infarction (1983) (0)
Ventricular Septal Rupture: A Review of Clinical and Physiologic Features (2005) (0)
Left and right ventricular function after streptokinase reperfusion: assessment by gated blood pool scans (1987) (0)
Function After Pulmonary Arterial Constriction (1973) (0)
Exercise gated blood pool scan at 6 months to assess myocardial salvage from acute streptokinase therapy (1985) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Herman Kalman Gold?

Herman Kalman Gold is affiliated with the following schools: